Your browser doesn't support javascript.
loading
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.
Lanfranconi, Silvia; Scola, Elisa; Meessen, Jennifer M T A; Pallini, Roberto; Bertani, Giulio A; Al-Shahi Salman, Rustam; Dejana, Elisabetta; Latini, Roberto.
Afiliación
  • Lanfranconi S; Department of Neurology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Scola E; and Department of Neuroradiology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Meessen JMTA; Department of Cardiovascular Medicine, Institute for Pharmacological Research Mario Negri IRCCS, Milan, Italy.
  • Pallini R; Department of Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Bertani GA; Department of Neurosurgery, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Al-Shahi Salman R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Dejana E; Laboratory of Vascular Biology, IFOM, Firc Institute for Molecular Oncology, Milan, Italy.
  • Latini R; Department of Cardiovascular Medicine, Institute for Pharmacological Research Mario Negri IRCCS, Milan, Italy. Electronic address: roberto.latini@marionegri.it.
Lancet Neurol ; 22(1): 35-44, 2023 01.
Article en En | MEDLINE | ID: mdl-36403580

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia